NEWG NEWGEN BIOPHARMA CORP: institutional ownership and insider trading
1 funds reported holding $0 of NEWGEN BIOPHARMA CORP in their latest 13F filings; in Q2 2026 funds net bought $0, with 1 new positions and 0 funds selling out.
1 funds reported holding $0 of NEWGEN BIOPHARMA CORP in their latest 13F filings; in Q2 2026 funds net bought $0, with 1 new positions and 0 funds selling out.